Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction.
about
Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCIInhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect MechanismsReducing myocardial infarct size: challenges and future opportunitiesMyocardial Dysfunction and Shock after Cardiac ArrestRole of the MPTP in conditioning the heart - translatability and mechanismMyocardial reperfusion injury: looking beyond primary PCIPostconditioning signalling in the heart: mechanisms and translatabilityNanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryNonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Novel adjunctive treatments of myocardial infarction.Identification of targeting peptides for ischemic myocardium by in vivo phage display.Cyclophilin D-sensitive mitochondrial permeability transition in adult human brain and liver mitochondria.Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injuryCoronary microvascular dysfunction: an updateDecrease in plasma cyclophilin A concentration at 1 month after myocardial infarction predicts better left ventricular performance and synchronicity at 6 months: a pilot study in patients with ST elevation myocardial infarctionFunctional and pharmacological characteristics of permeability transition in isolated human heart mitochondria.The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigsCardiovascular remodelling in coronary artery disease and heart failure.Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen speciesEffects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials.Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failureCyclosporin A and cardioprotection: from investigative tool to therapeutic agent.Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trialsPhysiological and pathological roles of the mitochondrial permeability transition pore in the heart.Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.Mitochondria as a drug target in ischemic heart disease and cardiomyopathyMyocardial ischemia-reperfusion injury: a neglected therapeutic target.Conditioning the heart to prevent myocardial reperfusion injury during PPCIIntralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.Mechanisms of cell death in heart disease.Cyclosporine A-nanoparticles enhance the therapeutic benefit of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model.Expert consensus document: Mitochondrial function as a therapeutic target in heart failurePostconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Postconditioning: from the bench to bedside.MRI in acute myocardial infarction.Infarct size reduction in patients with STEMI: why we can do it!Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives.
P2860
Q21261952-0F923A18-5AA7-4657-9700-DBC04F7BD7ACQ21296696-347303A9-DDDC-412F-BE1A-B45FCB9A5E94Q26775395-DC7EE1E8-07A0-4143-BBDC-B546340CDBF2Q26784080-08567615-3994-4818-A9E2-B3B00DB5BB8BQ26830560-CB794AFB-8319-41C6-9FB3-DB4F819FA2DDQ26991482-0917FAD9-F498-4978-BDCE-B2E0AD3CE957Q27021021-B034BC72-557B-4501-97AE-58EAC8254915Q27350484-AFDA4B19-7901-4C55-A566-F44BDFE1D82EQ28072918-9DEA6CA2-DCF0-469E-B1B4-BD5F2A2AFD8FQ30583012-BF6E3079-517D-48C2-8B65-B1395E636CB0Q33812924-ED470B26-0BC1-491E-BE60-01C8B438807FQ33819113-CC56AE6E-31F3-4887-AB0B-DDAD635808E3Q34152722-4B74A9BF-B047-4F56-A1B8-8DAFC99DA00FQ34193073-FDFD67F5-F690-4782-954E-140870E8D6AEQ34658569-EFEB7C2E-B923-4952-BA16-064B115FD192Q34780920-D2EDBBF4-E0AA-4D79-BFEB-62867C6E1923Q34807984-0CA32432-B162-40FF-A2F6-1F4C6F919101Q35085312-ADAEC700-AE04-4EE9-A1B5-E02216E4BE33Q35090566-E26F1883-C836-42C4-85AC-3B4DCFCF2863Q35113412-A973C1DA-215E-432F-BFD3-96CA62C50591Q35806794-44863453-8C8E-430B-B352-30928A0685E3Q35953116-D0AC1412-C6C4-4DFC-A6AF-8DA59EDF888EQ36024824-0014CF65-F4AB-47A6-9A95-BDB6111ADFBEQ36091469-DD0601A8-7B06-4AD1-BF39-2B9573128A98Q36193286-2F0BE158-F619-4BA4-ADAA-EE0D08086061Q36288965-E54D0691-5254-4AAD-9EE1-157396368B24Q36426316-DC55C321-C128-4EB5-8913-0F1472757825Q36497176-FAA0B845-8219-4826-AAEB-4CF93D00E9FBQ37140973-E9E8FD57-1C7F-4930-AF70-5D6B99183B93Q37160450-0A03D532-0F58-4EB8-A76E-C632A6F9CBAEQ37330076-F6C2691C-E99B-4388-8847-2F85C6ADB7C5Q37397001-8A05E540-1530-4290-8042-381C23FFCD67Q37699474-F6C7E054-77E4-4C39-96C8-1522E1BD713EQ37744271-3B3F0B83-2F4C-4CB9-A831-F64D052165B5Q37799471-488B96F1-38C7-4EB9-8B00-91A45AFF66DDQ37812993-CEC864D8-7269-4A5A-BDF8-D0B6B89B27FAQ37912851-5D13ADDB-7031-44BD-85F2-A415F738BDF3Q38010782-6EA9DA05-8F40-492E-83E4-D71283B67A77Q38075417-4AA31C0C-80FA-478B-A3D5-EAD7759367D9Q38124357-534F2627-FD1F-4B57-ADE7-502B07C5F47B
P2860
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effect of cyclosporine on left ...... erfused myocardial infarction.
@en
Effect of cyclosporine on left ...... erfused myocardial infarction.
@nl
type
label
Effect of cyclosporine on left ...... erfused myocardial infarction.
@en
Effect of cyclosporine on left ...... erfused myocardial infarction.
@nl
prefLabel
Effect of cyclosporine on left ...... erfused myocardial infarction.
@en
Effect of cyclosporine on left ...... erfused myocardial infarction.
@nl
P2093
P50
P1476
Effect of cyclosporine on left ...... erfused myocardial infarction.
@en
P2093
Catherine Sportouch
Didier Revel
Eric Bonnefoy
Gerald Gahide
Gilles Rioufol
Gérard Finet
Hélène Vernhet
Ingrid Sanchez
Michel Ovize
Nathan Mewton
P304
P356
10.1016/J.JACC.2009.10.052
P407
P577
2010-03-01T00:00:00Z